Ali, Zahid,Butcher, Kenneth John,Butt, Richard Philip,Felstead, Stephen John,Glatt, Sophie,McKernan, Ruth Mitchell,Panesar, Maninder
申请号：
AU2012324405
公开号：
AU2012324405B2
申请日:
2012.10.19
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The invention provides 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2- fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. In another aspect the invention provides the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4- yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
